Burkina Faso has stopped mass drug administration (MDA) for lymphatic filariasis in 93% of endemic districts in the country following the likely interruption of transmission of in 65 districts as of FY23 (October 2022 – September 2023). Prevalence of infection has been reduced significantly in the remaining five districts due to ongoing MDA.
Of the 48 ever trachoma endemic districts in Burkina Faso, 38 have also demonstrates that TF remains <5% among children ages 1-9 at least two years after MDA has stopped with the trachoma surveillance surveys. Burkina Faso has also begun working on its trachoma elimination dossier.
In FY24, blackfly breeding assessments were conducted, and an onchocerciasis pre-stop MDA was implemented with support from the Act | West program.
Burkina Faso has one of the longest standing schistosomiasis/soil-transmitted helminthiasis (SCH/STH) control programs in West Africa, conducting SCH/STH MDA since 2004. Burkina Faso have stopped STH MDA throughout the country since 2021. Burkina are currently developing a robust surveillance system that includes active case detection through SCH/STH integrated impact assessments. Between 2023 and 2024, Burkina Faso have re-evaluated 13 districts and have three more districts to be assessed before the end of the fiscal year.
Standard Disease-Specific Indicators as of FY21
FY21 is October 2020 through September 2021
of ever-endemic districts have stopped MDA as of FY21
(i.e. have passed stop MDA survey, TAS1 (First Transmission Assessment Survey))
of ever-endemic districts in post-surveillance phase as of FY21
(i.e. have passed last surveillance survey, TAS3 (third Transmission Assessment Survey))
of persons no longer at risk as of FY21 among those who were ever at risk
of ever-endemic districts have stopped MDA as of FY21
(i.e. have passed stop MDA survey, TIS (Trachoma Impact Survey))
of ever-endemic districts in post-MDA surveillance phase as of FY21
(i.e. have passed surveillance survey, TSS (Trachoma Surveillance Survey))*
*Burkina Faso conducted TSS in 36 HDs by the end of FY21 with results pending in one additional district.
of persons no longer at risk as of FY21 among those who were ever at risk
of ever endemic districts have been treated at least once as of FY21
(in cases where a country has more treated districts reported than, ever endemic, the adjusted percent is 100%)